Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone IV to Treat Status Epilepticus
April 15, 2016A Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of ganaxolone IV is expected to initiate in the first half of 2016.
More »
Syndax Announces Entinostat Data to be Presented at the American Association for Cancer Research (AACR) 2016 Annual Meeting
April 11, 2016Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), announced today that entinostat will be the subject of seven investigator presentations, at the AACR Annual Meeting 2016 in New Orleans, Louisiana.
More »
REVA MEDICAL, INC. (ASX: RVA) ("REVA" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THAT ITS BOARD OF DIRECTORS HAS ELECTED BRIAN DOVEY TO BE CHAIRMAN.
March 31, 2016MR. DOVEY WILL REPLACE ROBERT STOCKMAN, THE COMPANY'S CURRENT CHAIRMAN, WHO WILL REMAIN ON THE BOARD AS A NON-EXECUTIVE DIRECTOR.
More »